In diagnosis, molecular diagnostics brought transformative changes leading to insight in research and treatment of many diseases.
Molecular diagnostics detect and measure the presence of genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level.
Molecular diagnostics is laboratory tests used to identify a disease, or the predisposition to a disease, by analyzing DNA- (deoxyribonucleic acid) or RNA (ribonucleic acid) or their proteins, in humans or, in the case of infections, in microbes. It includes all tests and methods to identify a disease and understand the predisposition for a disease analyzing DNA or RNA of an organism.
With the help of molecular diagnostic,the understanding of diseases is now possible at much earlier stage, which is not possible using traditional methods and it also facilitates understanding of gene pattern and detecting of cell behavior.
The market value for molecular diagnostics is expected to reach 19,683 Million in 2026. North America accounts for the highest market share followed by Europe and Asia-Pacific. In 2017, North America holds the market value of USD 3730 Million.
The market is driven by increasing number of incidence and prevalence of diseases like cancer, infectious disease, respiratory disorders, hematology disorders etc. Research and development of techniques in molecular diagnostics also influences the market.
Molecular diagnostics tests are applied in the area of infectious disease like human immunodeficiency virus(HIV), influenza virus detection etc., oncological disease like breast cancer, prostate cancer, colorectal cancer, lung cancer etc., respiratory diseases like cystic fibrosis etc. In hematological diseases like acute myeloid leukemia etc., molecular diagnostics tests are helpful.
Biomarkers detection for cancer disease are also done through molecular diagnostics tests.
Molecular diagnostics tests include technologies like polymerase chain reaction (PCR), next generation sequencing (NGS), In situ hybridization (ISH), mass spectrometry etc., used for the detection. Now a days, these technologies are getting advanced and automated that reduce the labor and time of results.
Roche is covering the maximum market with approximately 26 percent. Its product Cobas system is being used widely in the diagnosis of human papilloma virus (HPV), Staphylococcus aureus(SA) and methicillin-resistant Staphylococcus aureus(MRSA), Serine/threonine-protein kinase B-rafRapidly Accelerated Fibrosarcoma (BRAF) mutation test, Epidermal Growth Factor Receptor (EGFR) test etc.
Hologic Inc shares the approximately 15 percent of molecular diagnostics market. Panther system, a proprietary product of the company, used in the diagnosis of influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, rhinovirus, parainfluenza virus, gram-positive bacterium Streptococcus agalactiae etc.
In 2016, Danaher Corporation acquired the Cepheid Inc a molecular diagnostics company. In August 2016, the Myriad genetics completed the acquisition of Assurex Health, Inc. In May 2016, Myriad genetics completed the acquisition of Sividon Diagnostics GmbH, a leading breast cancer prognostic company.
Key Question Covered:
- Molecular diagnostics Applications
- Global Market size of Molecular diagnostic
- Global Market size of Molecular diagnostics by application
- Global Market size of Molecular diagnostics by technologies
- North America Market size of Molecular Diagnostics
- North America Market size of Molecular diagnostics by application
- North America Market size of Molecular diagnostics by technologies
- Europe Market size of Molecular Diagnostics
- Europe Market size of Molecular diagnostics by application
- Europe Market size of Molecular diagnostics by technologies
- Asia-Pacific Market size of Molecular Diagnostics
- Asia-Pacific Market size of Molecular diagnostics by application
- Asia-Pacific Market size of Molecular diagnostics by technologies
- Patent Landscape
- Market Drivers & Resistors
- Companies and Product Profile